Zaloguj się

Determining Optimal Cytotoxic Activity of Human Her2neu Specific CD8 T cells by Comparing the Cr51 Release Assay to the xCELLigence System

24.9K Views

11:31 min

August 8th, 2012

DOI :

10.3791/3683-v

August 8th, 2012


Przeglądaj więcej filmów

Cytotoxic Activity

Rozdziały w tym wideo

1:16

Generation of Short-term Human Antigen-specific CD8 T Cell Lines

2:55

Preparation of Breast Cancer Cells

4:19

Co-culture of Tumor with CD8 T Cells

5:45

Chromium Release Assay (CRA)

7:21

HER-2/neu p369-specific T Cell / SKBR3 Breast Cancer Cells Co-cultures

11:09

Conclusion

0:05

Title

Powiązane Filmy

article

08:04

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

11.5K Views

article

09:28

Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells

14.9K Views

article

10:14

Cell-based Flow Cytometry Assay to Measure Cytotoxic Activity

17.9K Views

article

13:59

High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds

1.9K Views

article

09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

371 Views

article

09:01

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

216 Views

article

08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

53.0K Views

article

10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

8.9K Views

article

05:21

Assessing Antibody-dependent, Cell-mediated Cytotoxicity in Cancer Cells using Antibody-Dependent Cell-Mediated Cytotoxicity Reporter Bioassay

224 Views

article

01:23

Test in vitro w celu oceny aktywności przeciwnowotworowej komórek CAR T specyficznych dla nowotworu

80 Views

JoVE Logo

Prywatność

Warunki Korzystania

Zasady

Badania

Edukacja

O JoVE

Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone